(7-(5-fluoro-2-methoxyphenyl)-2-((2-isopropoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)thieno[3,2-d]pyrimidin-6-yl)methanol |
(7-(5-fluoro-2-methoxyphenyl)-2-((2-isopropoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)thieno[3,2-d]pyrimidin-6-yl)methanol |
1462949-64-9 |
1H-Pyrazole-5-carbonitrile, 1-methyl-3-[(methylamino)methyl]- |
1-甲基-3-(甲氨基)甲基吡唑-5-甲腈 |
1454852-76-6 |
MK-8742 |
MK-8742 |
1444832-51-2 |
Aducanumab |
阿杜那单抗 |
1384260-65-4 |
C26H27Cl2FN6O3 |
561.44 |
1370651-20-9 |
AVL 292 benzenesulfonate |
1360053-81-1 |
1360053-81-1 |
3-(benzyloxy)oxan-4-one |
3-(benzyloxy)oxan-4-one |
1351450-56-0 |
(3S,4R)-4-aminotetrahydro-2H-pyran-3-ol |
(3S,4R)-4-氨基-3-羟基四氢吡喃 |
1309081-53-5 |
BMVC-8C3O |
BMVC-8C3O |
1301708-12-2 |
CDM-NAG |
CDM-NAG |
1299292-01-5 |
Benzenesulfonamide, 5-chloro-2-fluoro-4-[2-(4-pyridazinyl)-4-(trifluoromethyl)phenoxy]-N-1,3,4-thiadiazol-2-yl- |
Benzenesulfonamide, 5-chloro-2-fluoro-4-[2-(4-pyridazinyl)-4-(trifluoromethyl)phenoxy]-N-1,3,4-thiadiazol-2-yl- |
1235406-03-7 |
SRT3025 |
SRT 3025;SRT-3025 |
1231952-55-8 |
AMG-25 |
AMG25 |
1003311-62-3 |
SulfoniuM, (4-hydroxyphenyl)Methyl[(2-Methylphenyl)Methyl]-, (OC-6-11)-hexafluoroantiMonate(1-) (1:1) |
(4-羟苯基)甲基(2-甲基苄基)硫鎓六氟锑酸盐 |
141651-31-2 |
T-3775440 hydrochloride |
T-3775440盐酸盐 |
1422535-52-1 |
8-(2-amino-3-chloro-5-(1-methyl-1H-indazol-5-yl)pyridin-4-yl)-2,8-diazaspiro[4.5]decan-1-one |
CCT251921 |
1607837-31-9 |
FT-113 |
FT113 |
1630808-89-7 |
S49076 HCl |
5MG |
1265966-31-1 |
RIP2 kinase inhibitor 1 |
RIP2 kinase inhibitor 1 |
1423186-80-4 |
Pentanoic acid, 2-amino-5,5-difluoro-4,4-dimethyl-, (2S)- |
Pentanoic acid, 2-amino-5,5-difluoro-4,4-dimethyl-, (2S)- |
2095886-80-7 |